What does business segments — interest income, net mean?

This metric represents the net interest income generated specifically by the financial assets held within the Pharmaceuticals business segment. It reflects the returns earned on cash, cash equivalents, and marketable securities allocated to this segment's operations, offset by any interest expenses directly attributable to segment-specific financing activities. This figure provides insight into the segment's ability to generate non-operating income from its liquidity position.

Vertex Pharmaceuticals VRTX Business Segments — Interest income, net

Similar metrics at other companies

AMP

AMPHPharmaceutical Products — Investment Income Interest

$2.4M+14.9%

KNSAPharmaceutical — Investment Income Interest

$3.41M+49.1%

SNDXBiopharmaceutical Cancer Therapeutics — Interest Income Expense Net

-$3.56M+50.4%

ANABBiopharma Company — Interest Income Other

$2.33M-43.1%

BAXPharmaceuticals — Segment operating income

$46M-27.0%

DNLITherapeutics Segment — Interest and other income, net

$8.91M-29.3%

Other financials

Income statement

See full

Revenue$3.0B+7.8%

Gross profit$2.6B+7.8%

Operating income$1.1B+80.6%

Net income$1.0B+59.6%

EPS (diluted)$4.02+61.4%

Balance sheet

See full

Cash & equivalents$5.5B+17.5%

Total debt$2.0B+20.5%

Total equity$19.4B+17.4%

Total assets$26.5B+15.8%

Cash flow

See full

Operating cash flow$1.4B+74.4%

CapEx$133.4M+228%

Free cash flow$1.3B+66.4%

Valuation

See full

Market cap$120.61B+6.5%

Enterprise value$117.09B+6.3%

P/E27.8×—

P/S9.9×-0.3×

Profitability

See full

Gross margin86.2%+0.2pp

Operating margin38.3%—

Net margin35.5%—

FCF margin30.4%+20.2pp

Returns & leverage

See full

Return on equity24.2%—

Debt / equity0.1×0.0×

Current ratio3×+0.4×

Where this comes from

Reported directly by Vertex Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:InvestmentIncomeNet.

The official record: Vertex Pharmaceuticals’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Vertex Pharmaceuticals's business segments — interest income, net.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Vertex Pharmaceuticals's business segments — interest income, net?: Vertex Pharmaceuticals (VRTX) reported business segments — interest income, net of $114.8M in Q1 2026.
What does business segments — interest income, net mean?: This metric represents the net interest income generated specifically by the financial assets held within the Pharmaceuticals business segment. It reflects the returns earned on cash, cash equivalents, and marketable securities allocated to this segment's operations, offset by any interest expenses directly attributable to segment-specific financing activities. This figure provides insight into the segment's ability to generate non-operating income from its liquidity position.